Inventor
SUSAN M. FREIER
Inventor
US
Overview
Patents· 52 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes24%
C07HSugars10%
C12YEnzymes7%
C07KPeptides2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
12,595,485Modulation of prekallikrein (PKK) expression202612,584,128Compositions for modulating Ataxin 2 expression202612,509,681Antisense oligonucleotides directed to huntingtin202512,480,126Modulation of dystrophia myotonica-protein kinase (DMPK) expression202512,409,188Modulators of HSD17B13 expression202512,350,285Compounds and methods for reducing ATXN3 expression202512,343,357Compositions and methods for modulating MECP2 expression202512,297,431Modulation of huntingtin expression202512,281,305Compounds and methods for reducing prion expression202512,241,067Compounds and methods for reducing LRRK2 expression202512,180,479Compounds and methods for modulating ATXN1202412,168,766Modulators of APOL1 expression202412,157,890Modulators of MALAT1 expression202412,152,052Compounds and methods for reducing MECP2 expression202412,110,491Selective reduction of allelic variants202412,091,662Compositions for modulating tau expression202412,043,831Modulation of alpha synuclein expression202412,042,510Modulators of IRF4 expression202411,981,897Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression202411,926,825Compounds and methods for reducing ATXN2 expression202411,926,830Modulators of Complement Factor B202411,873,495Compounds and methods for reducing LRRK2 expression202411,840,686Modulation of prekallikrein (PKK) expression202311,834,660Compositions for modulating Ataxin 2 expression202311,781,143Modulators of PNPLA3 expression202311,761,000Compositions and their uses directed to huntingtin202311,744,846Allele specific modulators of P23H rhodopsin202311,732,265Compositions and methods for modulating complement factor B expression202311,713,462Modulation of GYS1 expression202311,633,483Modulators of PCSK9 expression202311,634,711Methods and compositions for modulating apolipoprotein (a) expression202311,591,595Compositions for modulating Tau expression202311,583,548Compounds and methods for reducing ATXN3 expression202311,566,245Oligomeric compounds comprising bicyclic nucleotides and uses thereof202311,547,718Modulators of FOXP3 expression202311,535,849Modulation of transthyretin expression202211,530,410Methods for treating hypercholesterolemia202211,525,136Modulators of APOL1 expression202211,447,521Compounds and methods for modulating angiotensinogen expression202211,434,488Compounds and methods for reducing ATXN3 expression202211,421,231Modulation of Huntington expression202211,376,273Modulation of factor 11 expression202211,365,416Modulators of EZH2 expression202211,339,393Compositions for modulating C9ORF72 expression202211,332,746Compounds and methods for reducing LRRK2 expression202211,312,962Modulators of diacyglycerol acyltransferase 2 (DGAT2)202211,312,964Compositions and methods for modulating growth hormone receptor expression202211,279,932Modulators of MALAT1 expression202211,241,451Modulators of IRF4 expression202211,236,339Modulation of GYS1 expression202211,214,803Modulators of YAP1 expression202211,208,650Modulators of IRF5 expression2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to IONIS PHARMACEUTICALS INC (50)· patent assignee history
2021–2026Based in US· patent location history
2022–2023Patents assigned to HOSPITAL FOR SICK CHILDREN (2)· patent assignee history
2023–2024Patents assigned to BIOGEN MA INC (2)· patent assignee history
2024Patents assigned to ASTRAZENECA AB (1)· patent assignee history
2025Patents assigned to CHDI FOUNDATION INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IONIS PHARMACEUTICALS INC | 50 | 2021–2026 |
| BIOGEN MA INC | 2 | 2023–2024 |
| HOSPITAL FOR SICK CHILDREN | 2 | 2022–2023 |
| ASTRAZENECA AB | 1 | 2024 |
| CHDI FOUNDATION INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 52 | 2021–2026 |